1. Plotkin, SA, Reef, S. Rubella vaccine. In: Plotkin, SA, Orenstein, WA eds. Vaccines, 4th edn. Saunders, 2004, pp. 707.
2. Ciofi, degli Atti ML, et al. . Do Changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy. Vaccine 2004; 22: 4351–4357.
3. Salmaso, S, et al. . Epidemiology of measles, mumps and rubella in Italy: estimates by simultaneous EPI cluster surveys of regions. Bulletin of the World Health Organization 1999; 77: 843–851.
4. Panagiotopoulos, T, Antoniadou, I, Valassi-Adam, E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. British Medical Journal 1999; 319: 1462–1467.
5.Ministry of Health. Decree 7 April 1999. New childhood compulsory and recommended immunization schedule. Official Bullettin (Gazzetta Ufficiale) no. 87, 15 April 1999 [in Italian].
6.Ministerial Decree 29 November 2001. Essential levels of health care. Official Bulletin (Gazzetta Ufficiale) no. 33, 8 February 2002. Ordinary supplement no. 26 [in Italian].
7.European Health for All Series. Health 21. The health for all policy framework for the WHO European Region. European Health for All Series, 1999, no. 6, p. 49.
8.State Regional Conference. Agreement between the central Government, Regions and Autonomous Provinces of Trento and Bolzano regarding the National Measles and Congenital Rubella Elimination Plan 2003-2007, 13 November 2003 (http://governo.it/backoffice/allegati/20894-1712.pdf). Accessed 4 May 2006.
9. Ciofi, degli Atti ML, et al. . State of progression of the National Measles and Congenital Rubella Elimination Plan. Bollettino Epidemiologico Nazionale 2006; 19(4): i–iii.
10. Gabutti, G, et al. . Epidemiology of measles, mumps and rubella in Italy. Epidemiology and Infection 2002; 129: 543–550.
11. Pebody, RG, et al. . The seroepidemiology of rubella in Western Europe. Epidemiology and Infection 2000; 125: 347–357.
12. Amela, C, Pachon, I, de Ory, F. Evaluation of the measles, mumps, and rubella immunisation programme in Spain by using a sero-epidemiological survey. European Journal of Epidemiology 2003; 18: 71–79.
13. Gioula, G, et al. . Seroepidemiology of rubella in northern Greece. European Journal of Clinical Microbiology and Infectious Diseases 2004; 23: 631–633.
14. Huerta, M, et al. . Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year-comparison. Preventive Medicine 2004; 39: 1223–1226.
15. Ciofi, degli Atti ML, et al. . First cases of rubella infection during pregnancy detected by new reporting system in Italy. Eurosurveillance 2006; 11: E060323.5.
16. Buffolano, W, et al. . Surveillance of congenital rubella: the experience of the Campania Perinatal Infections Registry. Bollettino Epidemiologico Nazionale 2003; 16(5): iv–v.
17. Revello, MG. One year after the 2002 rubella outbreak. Bollettino Epidemiologico Nazionale 2003; 16(5): iii–iv.
18.Ministry of Health. Decree 14 October 2004. Compulsory reporting of rubella infection in pregnancy and of congenital rubella syndrome/infection. Official Bulletin (Gazzetta Ufficiale) no. 259, 4 November 2004.
19. Lemos, C, et al. . New features of rubella in Spain: the evidence of an outbreak. Eurosurveillance 2004; 9: 9–11.
20. Tookey, P. Rubella in England, Scotland and Wales. Eurosurveillance 2004; 9: 21–23.
21. Terra, Abrami V. Current data from the National Statistics Institute regarding immigration and the number of registered immigrants in Italy. Communication at the conference: ‘Evaluation of number of immigrants in Italy’, Rome 15–16 December 2005.
22.WHO Regional Office for Europe. Eliminating measles and rubella and preventing congenital rubella infection. WHO European Region strategic plan 2005–2010. WHO, 2005.